Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
NCT00476437
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart
DRUG:
biphasic human insulin
Sponsor
Novo Nordisk A/S